Biotech IPO Watch: Simcere Pharmaceutical Group Supplies High-End Generics In China
Simcere Pharma (SCR) of China, a company that bills itself as a maker of branded generic drugs for the domestic (Chinese) market, has filed to make its IPO and list on the NYSE.